Important notice: I’m with our SEC lawyer and dealing with otc markets. It’s an error. We are NOT SEC delinquent getting it fixed now. $KOAN

Due to our previously filed Form 15, OTC Markets is requiring us to utilize their reporting format at this time. Once this transition is complete, we will return to SEC-standard formatting as we prepare our S-1 to meet the audit requirements necessary for Nasdaq. $KOAN

In the coming days, we will be announcing our partnership, merger, and the introduction of new management. While we advance these initial developments, we are actively engaged in pursuing additional opportunities to further strengthen our growth and long-term strategy. $KOAN

Another quick update: With the recently secured distribution agreement, the upcoming merger, and the launch of new product lines, we anticipate significantly stronger revenue growth, with current run rate over $2,200,000, through the end of 2025 and into 2026. $KOAN

For those asking questions. I am currently at the airport en route to New Jersey to finalize our merger. Tomorrow, we will be meeting with our newly acquired investment banking team to advance the next phase of our strategy. $KOAN

We are pleased to confirm that the agreement has been signed and mutually agreed upon. Details regarding the merger, including information about the combined company, the newly appointed CEO, and the expanded management team, will be formally announced in the coming days. $KOAN

Please be assured that we are actively engaged in negotiations and working diligently to resolve and eliminate legacy debt. At this time, we would like to clarify that there have been no changes to the current share structure. The merger announcement will expand on this. $KOAN

Our merger with Revive Regenerative is now public information. Revive has a current run rate that exceeds $1M USD monthly. Combined with our current sales and newly placed distribution, $KOAN is postioned for explosive growth. Next, we will announce the clean-up and partnership.

We have a Zoom meeting scheduled for tomorrow to finalize our Nasdaq partnership with a world-leading biologics company based in Israel. We are very excited about the opportunities this presents for both the near and long term growth of $KOAN. Further updates to follow.

Apollo Biowellness, Inc. Executes LOI with Revive Regenerative, Inc. a leader in the aesthetic laser and energy device industry serving plastic surgeons, dermatologists, med spas, and wellness centers. The surviving company will be Revive Regenerative, Inc. Target closing date

To be very clear. We are in the process of converting to Preferred Equity, which will not convert until after our planned uplisting down the road in 2026. More importantly, we are also in very advanced discussions to acquire approximately $1.5 million to $2 million in

Additionally, this week we’ve secured $3.5 million in new investor capital, further strengthening our financial position. Launching the first and only shelf stable biologic skin care cosmetics brand brings a value beyond excitement. $KOAN

Quick Update: As of today, our share structure remains unchanged. We have a Zoom meeting scheduled for this afternoon to finalize our Nasdaq partnership. As always, shareholders will be kept informed on all developments. This strategic partnership will position our Regenerative

Excellent meeting yesterday! Both parties intend to put pen to paper next week, fully executing our partnership with a Nasdaq listed company. This will instantly put Apollo and Revive on the global stage. Once completed, we will have several press releases ready to issue. We

Management is meeting today with our SEC counsel regarding the upcoming audits and the preparation of our S-1 filing, which marks a key step in returning to full SEC reporting status. As part of this process, we will also be withdrawing the currently effective Form 15-12G.

Highly productive meetings yesterday! Shareholders can expect news on this shortly. We are moving at a very aggressive pace to ensure a strong end of year and an even better 2026. As a brief update on the share structure: there have been no changes. Additionally, we are making